conference

American Gastroenterological Association (AGA) hosted the "Preparing for the NASH Epidemic: A Call to Action" conference virtually on July 10th, 2020. The conference agenda is below, complete with videos and PDF slide decks.

The conference paper was co-published in Gastroenterology, Diabetes Care, Metabolism and Obesity.

Steering Committee

Fasiha Kanwal, MD

Fasiha Kanwal, MD

Baylor College of Medicine

Jay H. Shubrook, DO

Jay H. Shubrook, DO

Touro University

Kenneth Cusi, MD

Kenneth Cusi, MD

University of Florida

Accordion Icon

Opening Remarks

9:00 AM
9:10 AM

Virtual Meeting Instructions

9:10 AM
9:40 AM
Accordion Icon

Session I: NASH Landscape

Session Chairs

Yamini Natarajan, MD

Yamini Natarajan, MD

Baylor College of Medicine

Zobair M. Younossi, MD

Zobair M. Younossi, MD

Inova Medicine Services

Accordion Icon

Session II: NASH

Session Chair

Elisabetta Bugianesi, MD, PHD

Elisabetta Bugianesi, MD, PHD

University of Torino

10:15 AM
10:20 AM
10:20 AM
10:30 AM
10:30 AM
10:40 AM

Understanding the Risk of and Risk Factors Associated with Progression to Advanced Liver Disease in Patients with NAFLD

10:40 AM
10:50 AM

Understanding the Risk of and Risk Factors Associated with Progression to Cardiovascular and Other Complications in Patients with NAFLD

10:50 AM
11:00 AM

Who should be screened for NAFLD/NASH in primary care population? When is it necessary?

11:10 AM
11:30 AM
11:30 AM
11:40 AM

Session II Break

Accordion Icon

Session III: Diagnosing NASH

Session Chairs

Christos Mantzoros, MD

Christos Mantzoros, MD

Harvard Medical School (Endocrine Society)

Stephen A. Harrison, MD

Stephen A. Harrison, MD

Pinnacle Clinical Research

11:45 AM
11:55 AM

Initial Evaluation of Patients with NAFLD: Clinical and Laboratory Testing in Primary Care

11:55 AM
12:05 PM

Initial Evaluation of Patients with NAFLD: Imaging, Other Non-invasive Testing in Primary Care

12:05 PM
12:15 PM

Who and When Should I Refer my Patient to a Hepatologist? To an Endocrinologist?

12:15 PM
12:25 PM
12:25 PM
12:35 PM

Bringing It All Together: Key Components in the Initial Evaluation and Referral of Patients with NAFLD; Role of Liver Biopsy, Non-Invasive Testing, and Risk Prediction Algorithms

Accordion Icon

Session IV: Management

Session Chairs

Robert H. Eckel, MD

Robert H. Eckel, MD

University of Colorado (ADA)

Sam Klein, MD

Sam Klein, MD

Washington University

2:00 PM
2:10 PM

Lifestyle Interventions for NAFLD and NASH: What Works and What Does Not Work for Patients with NAFLD

2:10 PM
2:20 PM

Pharmacotherapy: Expanding Care Beyond Diet and Exercise in NASH Management: Who should get it?

2:20 PM
2:30 PM

Surgical and Endoscopic Treatment Options in Patients with NAFLD/NASH

2:30 PM
2:40 PM

Co-management of T2DM and NASH: Current and Future Perspectives

2:40 PM
3:00 PM
Accordion Icon

Session V: What Tools Do We Have? What Do We Need?

Session Chair

Hashem El-Serag, MD

Hashem El-Serag, MD

Baylor College of Medicine (AGA)

3:10 PM
3:15 PM
3:45 PM
3:55 PM

Ongoing Surveillance of Patients with NAFLD/NASH: Who Can Be Managed in Primary Care; Frequency of Follow Up; Type of Surveillance Testing (Repeating Non-invasive Testing); Secondary Prevention

3:55 PM
4:05 PM

Screening for Liver Cancer in Patients with NAFLD

4:05 PM
4:15 PM

What Tools Do We Need to Improve Diagnosis and Management of NAFLD/NASH

4:15 PM
4:25 PM

Future Directions: What Are We Expecting? Screening, Risk Stratification, and Treatment.

4:25 PM
4:45 PM

Q&A on What Tools Do We Have and What Do We Need?

Accordion Icon

Conference Video

Watch recording of the full EoE Disease Severity Index Conference here.